Novel Mindray high sensitivity cardiac troponin I assay for single sample and 0/2-hour rule out of myocardial infarction: MERITnI study
The novel Mindray hs-cTnI assay enabled safe and early rule out of MI and cardiac death at very low concentrations in a diverse, cohort utilizing both single sample and 0/2-h rule out protocols, including early presenters.
Authors
- Stephen W. Smith (ORCID: https://orcid.org/0000-0002-9166-9804)
- Yader B. Sandoval (ORCID: https://orcid.org/0000-0003-4800-2972)
- Barrett Wagner (ORCID: https://orcid.org/0000-0002-5336-8285)
- Fred S. Apple (ORCID: https://orcid.org/0000-0002-5920-6498)
- Kevin Buda (ORCID: https://orcid.org/0000-0003-3465-5681)
- Anne Sexter
- Karen Schulz (ORCID: https://orcid.org/0000-0002-2725-5623)
Institutions
- University of Minnesota (US)
- Abbott Northwestern Hospital (US)
- Minneapolis Heart Institute Foundation (US)
- Hennepin Healthcare Research Institute (US)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1515/cclm-2024-1387
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hennepin Healthcare Research Institute